ReviewCureus2022

Sodium-Glucose Co-transporter 2 Inhibitors/Gliflozins: A New Miracle Therapy for Heart Failure Patients Irrespective of Diabetes Status?

Paghunda Ehsan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.